Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T M Wheeler

Showing results (121-130 of 136) with videos related to

Pageof 14
Sort By:
The Journal of Urology|March 1, 1986
The prognostic significance of post-irradiation biopsy results in patients with prostatic cancerP T Scardino, J M Frankel, T M Wheeler, et al.
Cancer Research|January 13, 2001
Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikreinK M Slawin, S F Shariat, C Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1996
Reduced levels of transforming growth factor beta receptor type II in human prostate cancer: an immunohistochemical studyR H Williams, A M Stapleton, G Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1995
Association of p53 mutations with metastatic prostate cancerJ A Eastham, A M Stapleton, A E Gousse, et al.
Human Gene Therapy|May 26, 1999
In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trialJ R Herman, H L Adler, E Aguilar-Cordova, et al.
Urology|February 2, 2000
"BPSA," a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasiaS D Mikolajczyk, L S Millar, T J Wang, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1994
The most promising surrogate endpoint biomarkers for screening candidate chemopreventive compounds for prostatic adenocarcinoma in short-term phase II clinical trialsD G Bostwick, H B Burke, T M Wheeler, et al.
Urology|February 1, 1997
Adenovirus-mediated suicide gene therapy for experimental bladder cancerM A Sutton, S A Berkman, S H Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1997
Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastasesA M Stapleton, T L Timme, A E Gousse, et al.
The Prostate|February 15, 2001
Leptin and prostate cancerS Chang, S D Hursting, J H Contois, et al.
Pageof 14

Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
The Journal of Urology|March 1, 1986
The prognostic significance of post-irradiation biopsy results in patients with prostatic cancerP T Scardino, J M Frankel, T M Wheeler, et al.
Cancer Research|January 13, 2001
Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikreinK M Slawin, S F Shariat, C Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1996
Reduced levels of transforming growth factor beta receptor type II in human prostate cancer: an immunohistochemical studyR H Williams, A M Stapleton, G Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1995
Association of p53 mutations with metastatic prostate cancerJ A Eastham, A M Stapleton, A E Gousse, et al.
Human Gene Therapy|May 26, 1999
In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trialJ R Herman, H L Adler, E Aguilar-Cordova, et al.
Urology|February 2, 2000
"BPSA," a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasiaS D Mikolajczyk, L S Millar, T J Wang, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1994
The most promising surrogate endpoint biomarkers for screening candidate chemopreventive compounds for prostatic adenocarcinoma in short-term phase II clinical trialsD G Bostwick, H B Burke, T M Wheeler, et al.
Urology|February 1, 1997
Adenovirus-mediated suicide gene therapy for experimental bladder cancerM A Sutton, S A Berkman, S H Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1997
Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastasesA M Stapleton, T L Timme, A E Gousse, et al.
The Prostate|February 15, 2001
Leptin and prostate cancerS Chang, S D Hursting, J H Contois, et al.
Pageof 14